Blockade of growth factor synthesis and growth factor action: Two possible sites of interference in allograft vessel disease and coronary bypass or balloon injury

Metabolism: Clinical and Experimental

Volumn 45, Issue SUPPL.1, 1996, Pages 101-103

  Hayry P ^a,b   Aavik, E ^a   Myllarniemi M ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b Transplantation Laboratory   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPEPTIN; ANTIBODY; EPIDERMAL GROWTH FACTOR; GROWTH FACTOR; JB 3; PLATELET DERIVED GROWTH FACTOR B; SOMATOMEDIN C; SOMATOMEDIN C DERIVATIVE; SOMATOMEDIN C RECEPTOR; SOMATOSTATIN DERIVATIVE; UNCLASSIFIED DRUG;

ALLOTRANSPLANTATION; ANIMAL EXPERIMENT; AORTA GRAFT; ARTERIOSCLEROSIS; ARTERY INTIMA PROLIFERATION; ARTICLE; BALLOON DILATATION; BLOOD VESSEL INJURY; CELL DIVISION; CONTROLLED STUDY; DOSE RESPONSE; HISTOINCOMPATIBILITY; MAJOR HISTOCOMPATIBILITY COMPLEX; MINOR HISTOCOMPATIBILITY COMPLEX; NONHUMAN; PHOSPHORYLATION; PRIORITY JOURNAL; RAT; RECEPTOR BLOCKING; SMOOTH MUSCLE FIBER; SUBCUTANEOUS DRUG ADMINISTRATION;

ANIMALS; AORTA; ARTERIOSCLEROSIS; BALLOON DILATATION; BLOOD VESSELS; CELL DIVISION; CORONARY ARTERY BYPASS; EPIDERMAL GROWTH FACTOR; GROWTH INHIBITORS; GROWTH SUBSTANCES; INSULIN-LIKE GROWTH FACTOR I; MUSCLE, SMOOTH, VASCULAR; OLIGOPEPTIDES; PLATELET-DERIVED GROWTH FACTOR; RATS; RECEPTORS, SOMATOMEDIN; SOMATOMEDINS; SOMATOSTATIN; TRANSPLANTATION, HOMOLOGOUS;

EID: 0029809148     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0026-0495(96)90097-9     Document Type: Article

References (11)

1. Ross R: Rous-Whipple Award Lecture. Atherosclerosis: A defense mechanism gone awry. Am J Pathol 143:987-1002, 1993
2. 3H-thymidine incorporation by angiopeptin in the aorta of rabbits after balloon angioplasty. Transplant Proc 21:3695-3696, 1989
3. Foegh ML, Khirabadi BS, Chambers E, et al: Peptide inhibition of accelerated transplant atherosclerosis. Transplant Proc 21:3674-3676, 1989
4. Foegh ML, Khirabadi BS, Chambers E, et al: Inhibition of coronary artery transplant atherosclerosis in rabbits with angiopeptin, an octapeptide. Atherosclerosis 78:229-236, 1989
5. Lundergan C, Foegh ML, Vargas R, et al: Inhibition of myointimal proliferation of the rat carotid artery by the peptides, angiopeptin and BIM 23034. Atherosclerosis 80:44-55, 1989
6. Mennander A, Tiisala S, Halttunen J, et al: Chronic rejection in rat aortic allografts. An experimental model for transplant arteriosclerosis. Arteriosclerosis Thrombosis 11:671-680, 1991
7. Häyry P, Räisänen A, Ustinov J, et al: Somatostatin analog Lanreotide inhibits myocyte replication and several growth factors in allograft arteriosclerosis. FASEB J 7:1055-1060, 1993
8. Sell C, Dumenil G, Deveaud C, et al: Effect of a null mutation of the insulin-like growth factor 1 receptor gene on growth and transformation of mouse embryo fibroblasts. Mol Cell Biol 14:3604-3612, 1994
9. Jameson B, McDonnell J, Marini J, Korngold R: A rationally designed CD4 analogue inhibits experimental allergic encephalomyelitis. Nature 368:744-746, 1994
10. Häyry P, Myllärniemi M, Aavik E, et al: Stable D-peptide analog of insulin-like growth factor-I inhibits smooth muscle cell proliferation after carotid ballooning injury in the rat. FASEB J 9:1336-1344, 1995
11. Emanuelsson H, Beatt KJ, Bagger JP, et al: Long-term effects of angiopeptin treatment in coronary angioplasty. Reduction of clinical events but not angiographic restenosis. Circulation 91:1689-1896, 1995